BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 4956470)

  • 1. [Thio-tepa in recurring carcinomas of the cervix uteri. Results].
    Spitalier JM; Amalric R; Ayme Y; Desgeorge Y; Pollet JF
    Rev Fr Gynecol Obstet; 1966 Apr; 61(4):255-65. PubMed ID: 4956470
    [No Abstract]   [Full Text] [Related]  

  • 2. [CARCINOMA OF THE CERVIX UTERI. RECURRENCE. THIO-TEPA. 1-YEAR RESULT].
    SPITALIER JM; AMALRIC R; AYME Y; DESGEORGE Y
    Bull Fed Soc Gynecol Obstet Lang Fr; 1964; 16():177-9. PubMed ID: 14180109
    [No Abstract]   [Full Text] [Related]  

  • 3. [Changes in the functional state of the liver following endolymphatic administration of massive doses of thio-TEPA to patients with cancer of the uterine cervix].
    Moshkov BM; Ivanov OA
    Pediatr Akus Ginekol; 1972; 3():56-8. PubMed ID: 4633214
    [No Abstract]   [Full Text] [Related]  

  • 4. [Changes in the coagulating and anticoagulating systems of the blood in uterine cervix cancer patients following administration of massive doses of thio-TEPA].
    Kuliev ShB; Mamedov UA
    Vopr Onkol; 1969; 15(5):49-54. PubMed ID: 4243323
    [No Abstract]   [Full Text] [Related]  

  • 5. [Surgical adjuvant chemotherapy of stomach cancer, with special reference to follow-up study of thio-TEPA and future problems].
    Utsunomia J; Hishiki S; Nakamura T
    Gan No Rinsho; 1969 May; 15(5):474-9. PubMed ID: 4980605
    [No Abstract]   [Full Text] [Related]  

  • 6. Prophylactic effect of triethylenethiophosphoramide on the recurrence rate of superficial bladder tumors.
    Mukamel E; Zitron S; Nissenkorn I; Servadio C
    Isr J Med Sci; 1980; 16(9-10):714-6. PubMed ID: 6776072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent cancer of the cervix uteri.
    Graham J; Graham R; Hirabayashi K
    Surg Gynecol Obstet; 1968 Apr; 126(4):799-804. PubMed ID: 5643161
    [No Abstract]   [Full Text] [Related]  

  • 8. [Regional chemotherapy in far advanced forms of cancer of the uterine cervix].
    Nugmanov SN; Esenkulov AE
    Vopr Onkol; 1969; 15(5):82-4. PubMed ID: 4982807
    [No Abstract]   [Full Text] [Related]  

  • 9. [Personal experience with thio-tepa in the treatment of papillomas and superficial carcinomas of the bladder].
    Pellet A; Djulepa J
    Ther Umsch; 1970 May; 27(5):310-3. PubMed ID: 4994886
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prevention of dissemination of cervix neoplasms during surgery].
    Rismukhamedova RS; Musapirova NA
    Vopr Onkol; 1970; 16(9):74-7. PubMed ID: 4992021
    [No Abstract]   [Full Text] [Related]  

  • 11. [A lymphoepithelioma-like type of spinous-cell carcinoma of the cervix uteri].
    Pires MA; Andrade MJ; Guerra C; Silva TS; de Oliveira C; Beja M
    Acta Med Port; 1999; 12(4-6):235-7. PubMed ID: 10481329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The additional hormone and cytostatic therapy of the vterine cervix carcinoma. Based on a report from the meeting of the Northwest German Society of Gynecology in Bad Pyrmont on October 27-29, 1967].
    Wimhöfer H
    Geburtshilfe Frauenheilkd; 1968 Jul; 28(7):609-16. PubMed ID: 5681958
    [No Abstract]   [Full Text] [Related]  

  • 13. [Thio-tepa treatment for prevention of recurrence of surgically treated bladder tumors].
    Neagoe M
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1980; 29(4):259-65. PubMed ID: 6457322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of agranulocytosis following use of thio-TEPA].
    Vagina OG; Vasiliev AK
    Pediatr Akus Ginekol; 1972 Oct; 5():61-2. PubMed ID: 4633307
    [No Abstract]   [Full Text] [Related]  

  • 15. [A cytophotometric and karyometric study of the combined effect of thio-TEPA and protamine on tumor cells in tissue culture].
    Smertenko II; Brodskiĭ VIa; Braude AI
    Biull Eksp Biol Med; 1967 May; 63(5):77-80. PubMed ID: 4988364
    [No Abstract]   [Full Text] [Related]  

  • 16. Thio-TEPA and supervoltage radiotherapy for carcinoma of the ovary.
    Deutsch M; Parsons JA
    Cancer; 1972 Apr; 29(4):1038-42. PubMed ID: 4622786
    [No Abstract]   [Full Text] [Related]  

  • 17. (OUR EXPERIENCE IN USING THIOTEPA IN ONCOLOGICAL HOSPITALS.).
    KUNDZINYA I; TSEPLITT R; POORKALN T; AUZINYA A
    Acta Unio Int Contra Cancrum; 1964; 20():360-2. PubMed ID: 14151929
    [No Abstract]   [Full Text] [Related]  

  • 18. Minimal breast cancer. Clinical characteristics and treatment results.
    Semiglazov VF; Pavlov KA; Orlov AA
    Neoplasma; 1983; 30(3):365-9. PubMed ID: 6306493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preliminary results of a randomized study between intravesical adriamycin and thio-tepa in the treatment of superficial tumors of bladder].
    Allona Moncada A; Santos García Vaquero I; Polo Villar G; Díaz González R; González Martín M; Zuloaga Gómez A; Martínez Torres JL; Rodríguez Alvarez J; Duarte Vázquez JJ; Megino López JF
    Arch Esp Urol; 1984; 37(2):113-22. PubMed ID: 6431914
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of disseminated breast cancer with triethylen-thiophosphoramide (thio-tepa)].
    Madrigal Alonso PL; Perez Gomez FJ
    Acta Oncol (Madr); 1969; 8(2):135-42. PubMed ID: 4988905
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.